
doi: 10.5414/cpp47068
pmid: 19203543
Clinical Trials, Phase II as Topic, Clinical Trials, Phase I as Topic, Dose-Response Relationship, Drug, Maximum Tolerated Dose, Cytotoxins, Drug Administration Routes, Patient Selection, Humans, Cytostatic Agents, Medical Oncology, Biomarkers, Pharmacological
Clinical Trials, Phase II as Topic, Clinical Trials, Phase I as Topic, Dose-Response Relationship, Drug, Maximum Tolerated Dose, Cytotoxins, Drug Administration Routes, Patient Selection, Humans, Cytostatic Agents, Medical Oncology, Biomarkers, Pharmacological
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
